Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sincere CoTSE:7782 82 5-Year Yield-on-Cost % is 14.49 as of Aug. 06, 2026, which is 239% above its 10-year median of 4.27. GuruFocus rates TSE:7782 with a GF Score™ of 82/100 and a GF Value™ of 円687.31 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 317 Medical Devices & Instruments companies, Sincere Co ranks better than 94.32% on this metric.
Sincere Co's yield on cost for the quarter that ended in Dec. 2025 was 14.49.
The historical rank and industry rank for Sincere Co's 5-Year Yield-on-Cost % or its related term are showing as below:
TSE:7782'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.2 Med: 4.27 Max: 14.89
Current: 14.49
During the past 12 years, Sincere Co's highest Yield on Cost was 14.89. The lowest was 1.20. And the median was 4.27.
TSE:7782's 5-Year Yield-on-Cost % is ranked better than 94.32% of 317
companies
in the Medical Devices & Instruments industry
Industry Median: 2.41
vs TSE:7782: 14.49
Sincere Co (TSE:7782) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Sincere Co 5-Year Yield-on-Cost % Related Terms
TSE:7782 vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, Sincere Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sincere Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Sincere Co's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Sincere Co is calculated as
Sincere Co (TSE:7782) has a 5-Year Yield-on-Cost % of 14.49 as of Aug. 06, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sincere Co and its competitors. This is 239% above median its historical median of 4.27. Over the past decade, Sincere Co's 5-Year Yield-on-Cost % has ranged from 1.20 to 14.89. According to the industry distribution chart, Sincere Co ranks #18 out of 317 companies in the Medical Devices & Instruments industry, placing it in the top 5.7%.
Is Sincere Co's 5-Year Yield-on-Cost % too high?
Sincere Co's current 5-Year Yield-on-Cost % of 14.49 is 239% above median its 10-year median of 4.27. Over the past 10 years, this metric has ranged from a low of 1.20 to a high of 14.89. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.41. Sincere Co's value of 14.49 is 501.2% above this industry median. Based on the distribution chart, Sincere Co ranks #18 out of 317 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Sincere Co has a GF Score™ of 82/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sincere Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Sincere Co ranks #18 out of 317 companies for 5-Year Yield-on-Cost %. This places Sincere Co in the top 6% of its industry — outperforming the majority of peers. The industry median 5-Year Yield-on-Cost % is 2.41. Sincere Co's value of 14.49 is 501.2% above this benchmark. Historically, Sincere Co's own 5-Year Yield-on-Cost % has ranged from 1.20 to 14.89 over the past decade. While the company's 10-year median is 4.27 vs. the industry median of 2.41, Sincere Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.41, based on 317 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sincere Co's current 5-Year Yield-on-Cost % of 14.49 is 501.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Sincere Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sincere Co's current 5-Year Yield-on-Cost % is 14.49, which is 239% above median its own 10-year median of 4.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sincere Co stock overvalued right now?
Based on GuruFocus' analysis, Sincere Co (TSE:7782) is currently considered Significantly Undervalued. The stock's GF Value™ is 円687.31, compared to a current price of 円468.00 — trading 31.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 14.49, which is 239% above median its 10-year median of 4.27 and 501.2% above the Medical Devices & Instruments industry median of 2.41. Sincere Co's overall GF Score™ is 82/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Sincere Co (TSE:7782), the current 5-Year Yield-on-Cost % is 14.49 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sincere Co (TSE:7782) Overvalued in 2026?
Based on GuruFocus' analysis, Sincere Co stock appears to be undervalued.
The current stock price of 円468.00 is trading 31.9% below its estimated GF Value™ of 円687.31.
GuruFocus considers Sincere Co to be Significantly Undervalued.
Key valuation signals for TSE:7782:
5-Year Yield-on-Cost %: 14.49 (239% above median its 10-year median of 4.27)
GF Value™: 円687.31 vs. price of 円468.00 (31.9% below fair value)
Industry Position: 501.2% above the Medical Devices & Instruments median (#18 of 317)
No single metric tells the full story. See the TSE:7782 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens.As a company that manufactures and sells contact lenses, which are high-regulated medical devices, it place the highest priority on product safety and quality control, while working closely with company's customers to develop a variety-of-products and sell them at affordable prices to please as many customers as possible. The company opperates domestically as well as internationally.
82GF Score
Get the complete analysis for TSE:7782
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7782 has been successfully added to your 
